Published in

Wiley, Diabetes, Obesity and Metabolism, 7(22), p. 1220-1225, 2020

DOI: 10.1111/dom.14024

Links

Tools

Export citation

Search in Google Scholar

Angiogenic T cells are decreased in people with type 2 diabetes mellitus and recruited by the dipeptidyl peptidase‐4 inhibitor Linagliptin. A subanalysis from a randomized, placebo controlled trial (RELEASE study)

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO